The DSP Gene Dilated Cardiomyopathy with Woolly Hair, Keratoderma, and Tooth Agenesis Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the DSP gene. These mutations are associated with a rare genetic condition that manifests as a combination of dilated cardiomyopathy (a form of heart disease that affects the heart's ability to pump blood), woolly hair, palmoplantar keratoderma (thick skin on the palms and soles), and tooth agenesis (missing teeth). The test is critical for individuals showing symptoms of these conditions or those with a family history, providing essential information for accurate diagnosis, management, and genetic counseling. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the comprehensive insights it offers into managing this complex genetic disorder.
The DBH Gene Dopamine beta-hydroxylase (DBH) deficiency genetic test is a specialized diagnostic tool used to detect abnormalities or mutations in the DBH gene, which can lead to dopamine beta-hydroxylase deficiency. This condition is rare and affects the body's ability to produce norepinephrine and epinephrine from dopamine, leading to various autonomic nervous system dysfunctions. Symptoms can include orthostatic hypotension, ptosis, nasal congestion, and severe physical fatigue.
The test is performed by DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The procedure involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to identify any mutations in the DBH gene.
The cost of the DBH Gene Dopamine beta-hydroxylase (DBH) deficiency genetic test at DNA Labs UAE is 4400 AED. This cost covers the entire testing process, from sample collection to the analysis and reporting of results. It is important for patients considering this test to consult with a healthcare provider to understand the implications of the results and potential next steps in managing the condition if a mutation is detected.
The "SCN1B Gene Familial Atrial Fibrillation Type 13 Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the SCN1B gene, which have been associated with Familial Atrial Fibrillation Type 13. Atrial fibrillation (AF) is a common cardiac rhythm disorder that leads to an irregular and often rapid heart rate. The familial form of this condition suggests a genetic component, where specific gene mutations, such as those in the SCN1B gene, are inherited and can significantly increase the risk of developing AF.
This genetic test plays a crucial role in early detection and management of the condition, particularly for individuals with a family history of atrial fibrillation. By analyzing the DNA for specific mutations in the SCN1B gene, healthcare providers can identify individuals at risk, enabling proactive monitoring and implementation of preventive strategies to mitigate complications associated with atrial fibrillation, such as stroke and heart failure.
The test is conducted at DNA Labs UAE, a facility known for its advanced genetic testing services. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the genetic variants associated with this condition. Given the potential health implications and the benefits of early intervention, the test represents a valuable tool for at-risk individuals and their healthcare teams in managing and potentially preventing the onset of familial atrial fibrillation.
The SCN5A Gene Heart Block Progressive Familial Type 1A Genetic Test is a sophisticated diagnostic procedure aimed at identifying mutations in the SCN5A gene, which are implicated in the development of Progressive Familial Heart Block Type 1A (PFHB1A). This condition is a form of heart block that is inherited in an autosomal dominant pattern, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder. It is characterized by a progressive decrease in the heart's ability to conduct electrical signals, leading to irregular heartbeats and potentially serious heart complications.
The SCN5A gene plays a crucial role in the proper function of heart muscle cells, particularly in the generation and propagation of electrical signals that control the heartbeat. Mutations in this gene can disrupt these electrical signals, leading to the symptoms associated with PFHB1A.
The test is conducted at DNA Labs UAE, a state-of-the-art facility known for its expertise in genetic testing and personalized medicine. The procedure involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific genetic alterations in the SCN5A gene.
The cost of the SCN5A Gene Heart Block Progressive Familial Type 1A Genetic Test is 4400 AED. This investment includes the comprehensive analysis of the gene, the expertise of the genetic counselors and medical professionals at DNA Labs UAE, and the detailed report provided to the patient or their healthcare provider. This report not only offers a diagnosis but can also guide treatment decisions and help in the management of the condition.
Given the genetic nature of PFHB1A, this test is particularly recommended for individuals with a family history of heart block or related cardiac issues. Early detection through genetic testing can be crucial in managing the condition effectively, preventing complications, and improving the quality of life for those affected.
The LMNA Gene Heart-hand syndrome Slovenian type genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the LMNA gene associated with Heart-hand syndrome, Slovenian type. This condition is a rare genetic disorder characterized by a combination of heart disease, particularly cardiomyopathy or arrhythmias, and deformities in the hands and upper extremities. The LMNA gene plays a crucial role in the structure and function of cells in the body, and mutations in this gene can lead to a variety of health issues, including those affecting the heart and limbs.
Given the rarity and specific genetic basis of this syndrome, the test is vital for accurate diagnosis, enabling targeted management and treatment strategies for affected individuals. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any mutations in the LMNA gene that are indicative of Heart-hand syndrome, Slovenian type.
DNA Labs UAE offers this comprehensive genetic test for a cost of 4400 AED. The facility is equipped with state-of-the-art technology and staffed by experts in genetics and molecular biology, ensuring high accuracy and reliability of the test results. Individuals who have a family history of Heart-hand syndrome, Slovenian type, or exhibit symptoms related to the condition are candidates for this test. Early diagnosis through genetic testing can significantly improve the management of the syndrome, allowing for timely interventions and a better understanding of the condition's progression and implications.
The "DNAJC19 Gene Cardiomyopathy Dilated with Ataxia Genetic Test" is a specialized diagnostic tool used to identify mutations in the DNAJC19 gene, which are associated with a rare genetic disorder. This condition is characterized by dilated cardiomyopathy, a heart condition that affects the heart's ability to pump blood efficiently, coupled with ataxia, a neurological sign consisting of lack of voluntary coordination of muscle movements. The test is crucial for early detection, which can lead to better management of the symptoms and a more targeted approach to treatment.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or a cheek swab. The sample is then analyzed to detect any genetic abnormalities in the DNAJC19 gene. Given the complexity of the test and the expertise required to interpret the results, it is priced at 4400 AED.
This test is particularly important for individuals with a family history of dilated cardiomyopathy or ataxia, as it can provide essential information for genetic counseling and guide decisions regarding family planning. Moreover, it can also help in the identification of other family members who may be at risk of developing the condition.
The LMNA Gene Cardiomyopathy Dilated with Hypergonadotropic Hypogonadism Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE. This test, priced at 4400 AED, is designed to identify mutations in the LMNA gene, which have been associated with a unique form of cardiomyopathy accompanied by hypergonadotropic hypogonadism. Dilated cardiomyopathy (DCM) is a condition characterized by the enlargement and weakening of the heart's ventricles, which can lead to heart failure and arrhythmias. Hypergonadotropic hypogonadism is a condition where the gonads produce insufficient sex hormones, leading to delayed or absent puberty and reproductive issues, due to a lack of response despite high levels of stimulating hormones.
The LMNA gene encodes lamin A and C, types of nuclear envelope proteins that provide structural support and play a role in gene regulation. Mutations in this gene can disrupt these functions, leading to a variety of diseases, including the specific type of cardiomyopathy associated with hypergonadotropic hypogonadism.
By undergoing this genetic test, individuals suspected of having this condition or those with a family history of similar symptoms can gain valuable insights into their genetic makeup. The results can guide healthcare professionals in developing a personalized treatment plan that addresses both the cardiac and hormonal aspects of the condition. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, this test represents a crucial step towards accurate diagnosis and management of this complex condition.
The "DSP Gene Cardiomyopathy Dilated with Woolly Hair and Keratoderma Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE. This test is designed to identify mutations in the DSP gene, which are associated with a unique condition that manifests as dilated cardiomyopathy, a form of heart disease that affects the heart's ability to pump blood effectively. Additionally, individuals with mutations in the DSP gene may exhibit distinctive physical characteristics such as woolly hair and keratoderma, a skin condition characterized by thickened skin on the palms of the hands and soles of the feet.
Understanding the genetic underpinnings of this condition is crucial for accurate diagnosis, management, and treatment planning. By pinpointing the specific mutations in the DSP gene, healthcare providers can offer targeted therapies, monitor the progression of the disease more closely, and provide genetic counseling for affected individuals and their families.
The test is priced at 4400 AED and is conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services. The cost of the test reflects the comprehensive analysis and the specialized technology employed to detect mutations in the DSP gene accurately. Patients and healthcare providers opting for this test can expect reliable results that will aid in the better understanding and management of this complex condition.
The "CAV3 Gene Cardiomyopathy Familial Hypertrophic Genetic Test" is a specialized diagnostic tool designed to identify mutations in the CAV3 gene, which are linked to familial hypertrophic cardiomyopathy (HCM). This condition is characterized by the thickening of the heart muscle, potentially leading to heart failure and sudden cardiac death. Early detection through genetic testing is crucial for managing the condition, enabling personalized treatment plans and monitoring for affected individuals.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the test is 4400 AED. By analyzing a small sample of the patient's DNA, the test can pinpoint specific genetic alterations in the CAV3 gene, providing valuable insights into the patient's condition and risk factors. This information is vital for family members as well, as it helps identify carriers or those at risk of developing HCM, thereby facilitating preventive measures and early interventions.
The MYH7 gene plays a crucial role in the development and function of the heart muscle. Mutations in this gene are associated with familial hypertrophic cardiomyopathy type 1 (HCM1), a genetic condition characterized by the thickening of the heart muscle, which can lead to heart failure and sudden cardiac death. Early detection and management are essential for individuals with a family history of this condition.
DNA Labs UAE offers a genetic test specifically designed to identify mutations in the MYH7 gene associated with familial hypertrophic cardiomyopathy type 1. The test is a critical tool for individuals with a family history of HCM1, as it can provide valuable information for early intervention and management strategies to mitigate the risks associated with this condition.
The cost of the MYH7 Gene Cardiomyopathy Familial Hypertrophic Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This investment in health can provide peace of mind and crucial insights for affected individuals and their families, enabling them to make informed decisions about their health and lifestyle adjustments to manage the condition effectively.
